Epinephrine Market Analysis

  • Report ID: 4413
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Epinephrine Market Analysis

Application (Cardiac Arrest, Anaphylaxis, Superficial Bleeding, Respiratory Disorders)

The global epinephrine market is segmented and analyzed for demand and supply by application into cardiac arrest, anaphylaxis, superficial bleeding, respiratory disorders, and others. Out of these five types of segments, the anaphylaxis segment is anticipated to hold the highest share over the forecast period. The growth of the segment can be attributed to the rising development of technologically advanced products from the key players, and the globally increasing prevalence of anaphylaxis in pediatrics as well as in adults. For instance, in a clinical study, it was observed that the prevalence of anaphylaxis in children ranges from 1 to 762 per 100,000 person-years. This prevalence rate varied throughout continents; such, in Europe it ranged from 2.4 to 762 per 100,000 person-years, whereas it ranges between 0.8 to 72 per 100,000 person-years in North America. Moreover, the anaphylaxis incidence rate in the pediatric population ranges from 0.05% to 1.7% throughout the world.

Type (Prefilled Syringes, Auto-Injectors, Ampoules & Vials)

The global epinephrine market is also segmented and analyzed for demand and supply by type into epinephrine prefilled syringes, epinephrine auto-injectors, ampoules & vials, and others. Amongst these segments, the epinephrine auto-injectors segment is expected to garner a significant share. The growth of the segment can be attributed to their easy availability, easy to use, and great efficiency in treating acute anaphylaxis. On the other hand, the prefilled syringes segment is projected to witness notable growth during the forecast period, owing to its surging demand in hospitals and clinics for treating several illnesses, coupled with its rapid responsive rate in the treatment of emergency allergic reactions.

Our in-depth analysis of the global market includes the following segments:

              By Type

  • Epinephrine Prefilled Syringes
  • Epinephrine Auto-Injectors
  • Ampoules & Vials
  • Others

              By Application

  • Cardiac Arrest
  • Anaphylaxis
  • Superficial Bleeding
  • Respiratory Disorders
  • Others

              By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4413
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of epinephrine is evaluated at USD 1.37 billion.

The epinephrine market size was over USD 1.25 billion in 2024 and is likely to exceed USD 5.77 billion by the end of 2037, witnessing over 12.3% CAGR during the forecast period i.e., between 2025-2037. Upsurge in chronic respiratory disorders, growing occurrence of several types of allergic reactions, escalation in cardiac arrests will drive the market growth.

North America is predicted to account for largest industry share by 2037, attributed to escalating count of patients suffering from respiratory diseases such as asthma, coupled with rapidly expanding population in the region.

The major players in the market include Teva Pharmaceuticals Industries Ltd., Amneal Pharmaceuticals, Inc., Adamis Pharmaceuticals Corporation, Antares Pharma, Inc., Pfizer Inc., kaleo, Inc., ALK-Abelló A/S, Bausch Health Companies Inc., Viatris Inc., Abbott Laboratories.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample